Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants (PREMA)
|ClinicalTrials.gov Identifier: NCT00833222|
Recruitment Status : Completed
First Posted : February 2, 2009
Last Update Posted : December 26, 2017
|Condition or disease|
- To assess the feasibility of measuring body fat deposition by ADP in medically stable late gestation (32-35 weeks), premature infants during a period of rapid postnatal growth.
- To test the relationship between %BF by ADP to %BF by DXA, as well as characterize the relationship between these fat measures with bone measures by quantitative ultrasound and serum levels of insulin, IGF-1, IGF binding proteins, adiponectin and leptin.
- To perform inter- and intra-rater testing of anthropometric, ultrasound, and ADP measurements.
- Compare growth, body composition and bone strength between infants born preterm to infants born full term.
|Study Type :||Observational|
|Actual Enrollment :||72 participants|
|Official Title:||Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||June 2012|
Full Term Infants
Infants born between 37 4/7 weeks and 42 3/7 weeks gestation.
Infants born between 32 4/7 weeks and 35 3/7 weeks gestation.
- Growth trajectory [ Time Frame: Weekly ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00833222
|United States, Utah|
|University of Utah|
|Salt Lake City, Utah, United States, 84132|
|Principal Investigator:||Laurie Moyer-Mileur, PhD||University of Utah|
|Principal Investigator:||Kristine Jordan, MPH, PhD||University of Utah|